Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes

Netherlands Journal of Medicine

Volumn 63, Issue 2, 2005, Pages 52-58

  Verhage, D F ^a   Telgt, D S C ^a   Bousema, J T ^a   Hermsen, C C ^a   van Gemert, Gj A ^a   van der Meer, J W M ^a   Sauerwein, R W ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MALARIA VACCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONCENTRATION LOSS; CONTROLLED STUDY; DEPERSONALIZATION; DEPRESSION; EXPERIMENTAL INFECTION; FATIGUE; FEVER; HEADACHE; HUMAN; INCUBATION TIME; INFECTION RATE; LEUKOCYTE COUNT; MALAISE; MALARIA; MEDICAL DECISION MAKING; MENTAL DISEASE; MOSQUITO; NIGHTMARE; PARANOIA; PARASITEMIA; PATIENT MONITORING; PLASMODIUM FALCIPARUM; SAFETY; THROMBOCYTOPENIA; VOLUNTEER;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; BLOOD CHEMICAL ANALYSIS; CULICIDAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; HUMAN EXPERIMENTATION; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PROBABILITY; RESEARCH DESIGN; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 14844282763     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. WHO. http://www.rbm.who.int/cmc_upload/0/000/015/372/RBMInfosheet_1.htm.
2. Dubovsky FAAP. Creating a vaccine against malaria. 2001. http://www.malariavaccine.org/files/ Creating_a_Vaccine_against_Malaria.pdf
3. Herrera S, Perlaza BL, Bonelo A, Arevalo-Herrera M. Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int J Parasitol 2002;32(13):1625-35.
4. Church LW, Le TP, Bryan JP, et al. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis 1997;175(4):915-20.
5. Boyd MF, Kitchen SF. Observations on induced falciparum malaria. Am J Trop Med Hyg 1937;17:213-35.
6. Chulay JD, Schneider I, Cosgriff TM, et al. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg 1986;35(1):66-8.
7. Herrington DA, Clyde DF, Murphy JR, et al. A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines. Trop Geogr Med 1988;40(2):124-7.
8. Powell RD, McNamara JV. Infection with chloroquine-resistant Plasmodium falciparum in man: prepatent periods, incubation periods, and relationships between parasitemia and the onset of fever in non-immune persons. Ann N Y Acad Sci 1970;74(2)1027-41.
9. Ponnudurai T, Lensen AH, van Gemert GJ, Bensink MP, Bolmer M, Meuwissen JH. Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes. Parasitology 1989;98(Pt 2):165-73.
10. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile: a statement for health professionals. Circulation 1991;83:356-62.
11. Rickman LS, Jones TR, Long GW, et al. Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg 1990;43(5):441-5.
12. FG, Grady C. The ethical challenge of infection-inducing challenge experiments. Clin Infect Dis 2001;33(7):1028-33.
13. D'Acremont V, Landry P, Darioli R, Stuerchler D, Pecoud A, Genton B. Treatment of imported malaria in an ambulatory setting: prospective study. BMJ 2002;324(7342):875-87.
14. Jeffery GM, Young MD, Burgess RW. Early activity in sporozoite induced Plasmodium falciparum infections. Ann Trop Med Parasito1 1959;53:51-8.
15. Hermsen CC, de Vias SJ, van Gemert GJA, Telgt DSC, Verhege DF, Sauerwein RW. Testing vaccines in human experimental malaria: statistical analysis of parasitemia measured by a quantitative real-time polymerase chain reaction. Am J Trop Hyg 2004;71(2):196-201.
16. Richards MW, Behrens RH, Doherty JF. Short report: hematologic changes in acute, imported Plasmodium falciparum malaria. Am J Trop Med Hyg 1998;59(6):859.
17. Hviid L, Kurtzhals JA, Goka BQ, Oliver-Commey JO, Nkrumah FK, Theander TG. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect Immun 1997;65(10):4090-3.
18. Hviid L, Kemp K. What is the cause of lymphopenia in malaria? Infect Immun 2000;68(10):6087-9.
19. Kern P, Dietrich M, Hemmer C, Wellinghausen N. Increased levels of soluble Fas ligand in serum in Plasmodium Falciparum malaria. Infect Immun 2000;68(5):3061-3.
20. Glynn JR. Infecting dose and severity of malaria: a literature review of induced malaria. J Trop Med Hyg 1994;97(5):300-16.
21. Good MI, Shader RI. Lethality and behavioral side effects of chloroquine. J Clin Psychopharmacol 1982;2(1):40-7.
22. Mohan D, Mohandas E, Rajat R. Chloroquine psychosis: a chemical psychosis? J Natl Med Assoc 1981;73(11)1073-6.
23. Franzen D, Curtius JM, Heitz W, Hopp HW, Diehl V, Hilger HH. Cardiac involvement during and after malaria. Clin Invest 1992;70(8):670-3.
24. Sprague HB. The effects of malaria on the heart. Am Heart 1946;31:426-30.